RGC (Regencell Bioscience Holdings) Other Current Payables: $0.00 Mil (As of Dec. 2025)


RGC Regencell Bioscience Holdings Ltd RGC
34 GF Score
Price $6.37
! 2 Warning Signs
View Full Analysis

What is Regencell Bioscience Holdings Other Current Payables?

Regencell Bioscience Holdings RGC -20.28% 34 Other Current Payables is $0.00 Mil as of Dec. 2025. GuruFocus rates RGC with a GF Score™ of 34/100. The stock has 2 warning signs investors should review.

Regencell Bioscience Holdings's Other Current Payables for the quarter that ended in Dec. 2025 was $0.00 Mil.

Regencell Bioscience Holdings's quarterly Other Current Payables increased from Dec. 2024 ($0.00 Mil) to Jun. 2025 ($0.00 Mil) but then declined from Jun. 2025 ($0.00 Mil) to Dec. 2025 ($0.00 Mil).

Regencell Bioscience Holdings's annual Other Current Payables declined from Jun. 2023 ($0.01 Mil) to Jun. 2024 ($0.01 Mil) and declined from Jun. 2024 ($0.01 Mil) to Jun. 2025 ($0.00 Mil).

Regencell Bioscience Holdings Other Current Payables Related Terms

Regencell Bioscience Holdings Other Current Payables Historical Data

* Premium members only.

The historical data trend for Regencell Bioscience Holdings's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Regencell Bioscience Holdings Other Current Payables Chart

Regencell Bioscience Holdings Annual Data
Trend Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Other Current Payables
Get a 7-Day Free Trial 0.08 0.02 0.01 0.01 0.00

Regencell Bioscience Holdings Semi-Annual Data
Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.01 0.00 0.00 0.00
RGC
34GF Score
Regencell Bioscience Holdings Ltd RGC
Other Current Payables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Regencell Bioscience Holdings Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Frequently Asked Questions Learn more about Other Current Payables →
What does a Other Current Payables of $0.00 Mil mean?
Regencell Bioscience Holdings (RGC) has a Other Current Payables of $0.00 Mil as of Dec. 2025. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Regencell Bioscience Holdings and its competitors.
Is Regencell Bioscience Holdings' Other Current Payables too high?
Regencell Bioscience Holdings' current Other Current Payables is $0.00 Mil. Overall, Regencell Bioscience Holdings has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does Regencell Bioscience Holdings' Other Current Payables compare to SUPN and BCRX?
Regencell Bioscience Holdings' Other Current Payables of $0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Payables for a Drug Manufacturers company?
A good Other Current Payables depends on the Drug Manufacturers industry context. However, Other Current Payables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Payables mean?
A high Other Current Payables can signal that a stock is expensive relative to its fundamentals. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Regencell Bioscience Holdings and its competitors. Regencell Bioscience Holdings's current Other Current Payables is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Regencell Bioscience Holdings stock overvalued right now?
Regencell Bioscience Holdings (RGC) has a current Other Current Payables of $0.00 Mil. The current Other Current Payables is $0.00 Mil. Regencell Bioscience Holdings' overall GF Score™ is 34/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Payables calculated?
Other Current Payables is calculated from a company's financial statements. For Regencell Bioscience Holdings (RGC), the current Other Current Payables is $0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Regencell Bioscience Holdings Business Description

Address 29 Leighton Road, 9th Floor, Chinachem Leighton Plaza, Causeway Bay, Hong Kong, HKG
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.
34GF Score

Get the complete analysis for RGC

Other Current Payables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$6.37
Price